Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Edwards

Showing results (71-80 of 196) with videos related to

Pageof 20
Sort By:
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 30, 2020
The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?Salvatore Bellinvia, Christopher J Edwards, Matteo Schisano, et al.
The Cochrane Database of Systematic Reviews|November 14, 2014
Uricosuric medications for chronic goutAlison S R Kydd, Rakhi Seth, Rachelle Buchbinder, et al.
The Cochrane Database of Systematic Reviews|October 15, 2014
Allopurinol for chronic goutRakhi Seth, Alison S R Kydd, Rachelle Buchbinder, et al.
Autoimmunity Reviews|October 23, 2019
Can we wean patients with inflammatory arthritis from biological therapies?Christopher J Edwards, Mauro Galeazzi, Salvatore Bellinvia, et al.
Rheumatology (Oxford, England)|March 25, 2017
Dosing down with biologic therapies: a systematic review and clinicians' perspectiveChristopher J Edwards, Bruno Fautrel, Hendrik Schulze-Koops, et al.
RMD Open|August 11, 2025
Declaration on the use of social media for rheumatology professionalsLatika Gupta, Elena Nikiphorou, Loreto Carmona, et al.
Lupus|June 17, 2021
Lupus, vaccinations and COVID-19: What we know nowAlice Mason, Himashi Anver, May Lwin, et al.
Rheumatology (Oxford, England)|December 15, 2017
Dosing down with biologic therapies: a systematic review and clinicians' perspectiveChristopher J Edwards, Bruno Fautrel, Hendrik Schulze-Koops, et al.
The Journal of Rheumatology. Supplement|September 4, 2012
Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic reviewAlexandra N Colebatch, Jonathan L Marks, Désirée M van der Heijde, et al.
Autoimmunity Reviews|March 13, 2016
Are there dangers in biologic dose reduction strategies?Christopher K Y Chan, Christopher R Holroyd, Alice Mason, et al.
Pageof 20

Showing results (71-80 of 196) with videos related to

Sort By:
Pageof 20
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|May 30, 2020
The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?Salvatore Bellinvia, Christopher J Edwards, Matteo Schisano, et al.
The Cochrane Database of Systematic Reviews|November 14, 2014
Uricosuric medications for chronic goutAlison S R Kydd, Rakhi Seth, Rachelle Buchbinder, et al.
The Cochrane Database of Systematic Reviews|October 15, 2014
Allopurinol for chronic goutRakhi Seth, Alison S R Kydd, Rachelle Buchbinder, et al.
Autoimmunity Reviews|October 23, 2019
Can we wean patients with inflammatory arthritis from biological therapies?Christopher J Edwards, Mauro Galeazzi, Salvatore Bellinvia, et al.
Rheumatology (Oxford, England)|March 25, 2017
Dosing down with biologic therapies: a systematic review and clinicians' perspectiveChristopher J Edwards, Bruno Fautrel, Hendrik Schulze-Koops, et al.
RMD Open|August 11, 2025
Declaration on the use of social media for rheumatology professionalsLatika Gupta, Elena Nikiphorou, Loreto Carmona, et al.
Lupus|June 17, 2021
Lupus, vaccinations and COVID-19: What we know nowAlice Mason, Himashi Anver, May Lwin, et al.
Rheumatology (Oxford, England)|December 15, 2017
Dosing down with biologic therapies: a systematic review and clinicians' perspectiveChristopher J Edwards, Bruno Fautrel, Hendrik Schulze-Koops, et al.
The Journal of Rheumatology. Supplement|September 4, 2012
Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic reviewAlexandra N Colebatch, Jonathan L Marks, Désirée M van der Heijde, et al.
Autoimmunity Reviews|March 13, 2016
Are there dangers in biologic dose reduction strategies?Christopher K Y Chan, Christopher R Holroyd, Alice Mason, et al.
Pageof 20